Gene Switch Key to Fight Breast Cancer Identified

Genetic switch that has the potential to open up new treatments for breast cancer has been discovered by scientists. Researchers from the Garvan Institute of Medical Research in Sydney found the molecule, known as ELF5, which can turn genes on or off.

Breast Cancer - Prevention and Management with Lifestyle Changes
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.

By manipulating the molecule, the breast cancer cell's sensitivity to anti-oestrogen drugs used to treat breast cancer could be increased, the Sydney Morning Herald reported.

Oestrogen plays a key role in the breast cancers. Women, who do not experience much oestrogen, either, because they start menstruating later in life or begin menopause early, have a lower risk of having breast cancer.

Led by Professor Ormandy in collaboration with colleagues Maria Kalyga and David Gallego-Ortega, the finding established for the first time that there is a relation between the molecule and breast cancer.

Quiz on Breast Cancer
Breast cancer is one of the leading causes of cancer deaths among women. It is often said that a woman who breast-feeds is at a lower risk of developing cancer compared to another who does not .Are these mere old wives tales or is there some truth in it? This quiz on breast cancer has all the details.

The latest discovery made in collaboration with British researchers, raises the potential for drugs designed to reduce the amount of the molecule in those cancer cells dependent on ELF5 for proliferation.

The study has been outlined in the journal PLOS Biology.

Breast Self Examination
Slides and animation of Breast Self Examination for early detection of breast cancer lumps in women

Source-ANI

Research Sheds Light on The Factor That Could Determine Future Breast Cancer Treatment
The way in which a 'transcription factor' causes breast cancer to develop an aggressive subtype that lacks sensitivity to estrogen has been demonstrated by Australian researchers.